A carregar...
Aprepitant for the management of nausea with inpatient IV dihydroergotamine
OBJECTIVE: To assess the efficacy and tolerability of oral aprepitant, a substance P/neurokinin A receptor antagonist, in controlling nausea associated with IV dihydroergotamine (DHE) administered for medically refractory migrainous headache in patients not responding to standard antiemetics or with...
Na minha lista:
| Publicado no: | Neurology |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Lippincott Williams & Wilkins
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5067541/ https://ncbi.nlm.nih.gov/pubmed/27629088 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0000000000003206 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|